市场调查报告书
商品编码
1447636
光动力治疗设备市场规模- 按产品(二极体雷射、一次性光纤光传输设备)、应用(癌症、光化性角化病、痤疮、牛皮癣)、最终用途(医院、皮肤科诊所)和全球预测,2024 - 2032Photodynamic Therapy Devices Market Size - By Product (Diode Lasers, Disposable Fiber Optic Light Delivery Devices), Application (Cancer, Actinic Keratosis, Acne, Psoriasis), End-use (Hospitals, Dermatology Clinics) & Global Forecast, 2024 - 2032 |
在光化性角化症日益普及以及技术快速进步的推动下,2024年至2032年全球光动力治疗设备市场将以8.3%的CAGR成长。由于阳光照射等因素,光化性角化症病例不断增加,对有效治疗的需求更高。此外,改进的光源和光敏剂等技术创新正在提高光动力疗法的功效和精确度。
随着迎合这些进步的新产品的推出,市场将经历大幅成长。例如,2023 年 12 月,Zolar Technologies 和 Oral Science 推出了最新的 Photon EXE 软式组织二极体雷射。这款新型雷射系统采用紧凑便携的设计,配备大型触控萤幕控制面板,可提高效率和便利性。
光动力治疗设备产业根据产品、应用、最终用途和地区进行分类。
在应用方面,由于光化性角化病患病率不断上升,特别是在阳光照射较多的地区,到2032年,光化性角化病领域的市场收入将实现8.6%的CAGR。光动力疗法提供了一种副作用最小的有效治疗选择,推动了其在患者和医疗保健提供者中的采用。随着意识的不断增强以及越来越多的人寻求预防性皮肤病治疗,光化性角化病治疗对光动力治疗设备的需求可能会增加
到 2032 年,由于寻求各种皮肤病(包括癌性和癌前病变)的皮肤病治疗的人数不断增加,光动力治疗设备市场的皮肤科诊所最终用途部分的CAGR可能达到7.9% 。由于光动力疗法疗效确切且副作用最小,皮肤科诊所越来越多地采用光动力疗法,吸引了寻求安全有效治疗的患者。人们对皮肤健康和美容手术的日益重视也将推动皮肤科诊所对光动力治疗设备的需求。
由于癌症盛行率上升、医疗基础设施的进步以及创新医疗技术的采用增加,亚太地区光动力治疗设备产业从 2024 年到 2032 年将实现 8.8% 的CAGR。中国、日本和印度等国家正在展示对研发的大量投资。随着人口老化的迅速发展以及人们对光动力疗法益处的认识不断增强,该地区的产品需求预计将会上升。
Global Photodynamic Therapy Devices Market will grow at an 8.3% CAGR from 2024 to 2032, fueled by the growing prevalence of actinic keratosis coupled with rapid technological advancements. Actinic keratosis cases are on the rise due to factors like sun exposure, creating a higher demand for effective treatments. Additionally, technological innovations, such as improved light sources and photosensitizers, are enhancing the efficacy and precision of photodynamic therapies.
With new launches for catering to these advancements, the market will experience substantial growth. For instance, in December 2023, Zolar Technologies and Oral Science unveiled the latest Photon EXE soft-tissue diode laser. This new laser system boasts of a compact and portable design, featuring a sizable touchscreen control panel to render enhanced efficiency and convenience.
The photodynamic therapy devices industry is classified based on product, application, end-use, and region.
With respect to application, the market revenue from the actinic keratosis segment will experience 8.6% CAGR up to 2032 due to the rising prevalence of actinic keratosis, especially in regions with high sun exposure. Photodynamic therapy offers an effective treatment option with minimal side effects, driving its adoption among patients and healthcare providers alike. With the growing awareness and more individuals seeking preventative dermatological treatments, the demand for photodynamic therapy devices may rise in actinic keratosis treatment
The dermatology clinics end-use segment in the photodynamic therapy devices market may witness 7.9% CAGR through 2032, propelled by the rising number of individuals seeking dermatological treatments for various skin conditions, including cancerous and precancerous lesions. Dermatology clinics are increasingly adopting photodynamic therapy due to its efficacy and minimal side effects, attracting patients looking for safe and effective treatments. The growing emphasis on skin health and cosmetic procedures will also push the demand for photodynamic therapy devices in dermatology clinics.
Asia Pacific photodynamic therapy devices industry will record an 8.8% CAGR from 2024 to 2032, attributed to the rising cancer prevalence, advancements in healthcare infrastructure, and increased adoption of innovative medical technologies. Countries like China, Japan, and India are showcasing significant investments in research and development. With the burgeoning aging population and the growing awareness of the benefits of photodynamic therapy, the regional product demand is expected to rise.